1. Van Nuffel AM, Sukhatme V, Pantziarka P, Meheus L, Sukhatme VP, Bouche G. Repurposing Drugs in oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience. 2015; 9:513. DOI:
10.3332/ecancer.2015.513.
2. Ishimatsu Y, Mukae H, Matsumoto K, Harada T, Hara A, Hara S, et al. Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest. 2010; 138:730–733. DOI:
10.1378/chest.09-2358.
Article
3. Ohe M, Hashino S. A case of follicular B-cell lymphoma treated using clarithromycin. Korean J Hematol. 2011; 46:203–206. DOI:
10.5045/kjh.2011.46.3.203.
Article
4. Ohe M, Hashino S, Hattori A. Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone. Korean J Hematol. 2012; 47:293–297. DOI:
10.5045/kjh.2012.47.4.293.
Article
5. Coleman M, Leonard J, Lyons L, Szelenyi H, Niesvizky R. Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone. Semin Oncol. 2003; 30:270–274.
Article
6. Niesvizky R, Jayabalan DS, Christos PJ, Furst JR, Nabi T, Ely S, et al. BiRD (Biaxin (clarithromycin)/Revlimid (lenalidomide/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naïve symptomatic multiple myeloma. Blood. 2008; 111:1101–1109.
Article
7. Ohe M, Hashino S. Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin. Blood Res. 2016; 51:139–142. DOI:
10.5045/br.2016.51.2.139.
Article
8. D'Arena G, Grandone E, Di Minno MND, Musto P, Di Minno G. The anti-CD20 monoclonal antibody rituximab to treat acquired hemophilia A. Blood Transfus. 2016; 14:255–261. DOI:
10.2450/2015.0090-15.
9. Haider S, Latif T, Hochhausler A, Lucas F, Abdel Karim N. Waldenstrom's Macroglobulinemia and Peripheral Neuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes with a Bleeding Diathesis and Rash. Case Rep Oncol Med. 2013; 2013:890864. DOI:
10.1155/2013/890864.
Article
10. Mamlouk MD, Vansonnenberg E, Shankar S, Silverman SG. Omental cakes: unusual aetiologies and CT appearances. Insights Imaging. 2011; 2:399–408.
Article
11. Qi YG, Fang ZH, Huang Y. Analysis of computed tomography and pathological observations of non-Hodgkin lymphomas with peritoneal, omental and mesenteric involvement. Exp Ther Med. 2015; 9:891–894.
Article
12. Mizunoe S, Kadota J, Tokimatsu I, Kishi K, Nagai H, Nasu M. Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol. 2004; 4:1201–1207.
Article
13. Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H, Hibi T. Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. Anticancer Res. 2004; 24:3723–3730.
14. Nakamura M, Kikukawa Y, Takeya M, Mitsuya H, Hata H. Clarithromycin attenuates autophagy in myeloma cells. Int J Oncol. 2010; 37:815–820.
Article
15. Ploner C, Schmidt S, Presul E, Renner K, Schröksnadel K, Rainer J, et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid Biochem Mol Biol. 2005; 93:153–160.
Article